Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Renavance Pharma
AddedMar 20, 2024
UpdatedJun 18, 2026
Renavance Pharma

Renavance Pharma

Renavance Pharma, Inc.: A California-based pharmaceutical company since 2009.

HQ
Mill Valley, CA, US
Founded
2009
Overview
Compare
Fundraising
Employees

Renavance Pharma, Inc. is a pharmaceutical company.

Renavance Pharma, Inc. was incorporated in 2009 and is based in Mill Valley, California.

Renavance Pharma - Similar Companies

Aviv Pharma logo

Aviv Pharma

Revagenix logo

Revagenix

revagenix.com

Renerva logo

Renerva

renerva.com

Renovion logo

Renovion

renovion.com

Resq Pharmaceutical logo

Resq Pharmaceutical

resqpharm.com

Reven Holdings logo

Reven Holdings

reven.com

Theravance Biopharma logo

Theravance Biopharma

theravance.com

Ravn logo

Ravn

ravn.co

NeuroGenetic Pharmaceuticals logo

NeuroGenetic Pharmaceuticals

Neurana Pharmaceuticals logo

Neurana Pharmaceuticals

neuranapharma.com

Healthvest Craig Ranch logo

Healthvest Craig Ranch

NeuroFine logo

NeuroFine

Revance Therapeutics logo

Revance Therapeutics

revance.com

Endogenx logo

Endogenx

River 2 Renal logo

River 2 Renal

Renavance Pharma - Quick Facts

Who are Renavance Pharma's competitors?

Companies similar to Renavance Pharma include Aviv Pharma, Revagenix, Renerva and Renovion.

When was Renavance Pharma founded?

Renavance Pharma was founded in 2009.

Where is Renavance Pharma's headquarters located?

Renavance Pharma's headquarters is located in Mill Valley, CA, US.

When was Renavance Pharma's last funding round?

Renavance Pharma's most recent funding round was for $500k (USD) in July 2009.

How much has Renavance Pharma raised to-date?

As of Jul 1, 2009, Renavance Pharma has raised a total of $500k (USD).

How many employees does Renavance Pharma have?

Renavance Pharma has 6 employees as of Feb 5, 2024.

Renavance Pharma - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • SaaS
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 12 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research